Qlosi (Orasis Pharmaceuticals) approved to treat presbyopia.
Paul Smith
Advertisement
Articles by Paul Smith
Paul Smith shares an update on Orasis Pharmaceutical's CSF-1 drug and what to expect this year.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
AAOpt 2025: Dry eye and its neurological implications
2
AAOpt 2025: New approaches to managing age-related eye conditions
3
AAOpt 2025: Where low-level light therapies stand as dry eye treatments and myopia management
4
Seeing the signs: The subtle clues of human trafficking as seen in the clinic
5
.png "Optometry Times"){kind=logo}
